Protecting CEACAM1 Expression Prevents Diet‐Induced Metabolic Dysfunction and Hepatic Fibrosis in Male Mice
Obesity · 2026
DOI: 10.1002/oby.70302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Obesity, 2026. Verfasst von Raziyeh Abdolahipour und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA. Hauptthemen laut MEDLINE: Liver Cirrhosis, Diet, High-Fat, CEACAM1 Protein, Fatty Liver. Die Arbeit nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS.
Abstract (Originalsprache)
Objective
High‐fat diet represses Ceacam1 transcription via a PPARα‐mediated mechanism to cause insulin resistance before inflammation develops. The current study investigated whether mutating PPRE‐RXRα in Ceacam1 promoter prevents diet‐induced metabolic abnormalities and hepatic fibrosis in male C57BL6/J mice.
Methods
A knock‐in mouse line (KI) bearing mutation on PPRE‐RXRα in Ceacam1 promoter was generated. Male mice were fed with regular chow, high‐fat diet, or GAN diet for 1–4 months before insulin action was assessed in vivo by hyperinsulinemia‐euglycemia clamp analysis and energy balance was analyzed by indirect calorimetry. H&E and Sirius Red staining were carried out to detect steatohepatitis and hepatic fibrosis, respectively.
Results
Feeding with high‐fat or GAN diet for 1–4 months repressed hepatic CEACAM1 expression in wild‐type but not KI mice. Mutating PPRE‐RXRα prevented diet‐induced impairment of insulin clearance to maintain normoinsulinemia and insulin sensitivity. High‐fat diet failed to reduce energy expenditure and spontaneous locomotor activity in KI, as it did in wild‐type mice. GAN feeding for 4 months caused mounting of a Th1‐inflammatory response and hepatic fibrosis in wild‐type but not KI mice.
Conclusions
Blocking CEACAM1 repression while maintaining endogenous regulatory mechanisms and normal physiologic conditions sufficed to curb diet‐induced metabolic dysregulation, steatosis, energy imbalance, and MASH progression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA.
- Center for Diabetes and Endocrine Research, College of Medicine and Life Sciences, University of Toledo, Toledo, Ohio, USA.
- Section of Endocrinology and Metabolism and Yale Genome Editing Center, Department of Internal Medicine, Yale University School of Medicine, New Haven, Connecticut, USA.
- Program in Molecular Medicine, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
- Division of Endocrinology, Metabolism and Diabetes, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
- Diabetes Institute, Heritage College of Osteopathic Medicine, Ohio University, Athens, Ohio, USA.
ORCID-Profile: Saja S Khuder, William M Philbrick, Agnes O Portuphy, Sonia M Najjar
Förderung
- NIDDK NIH HHS
Zitieren
APA
Abdolahipour, R., Khuder, S. S., Philbrick, W. M., Portuphy, A. O., Belew, G. D., Fallouh, H. G., Muturi, H. T., Kim, B., Kim, J. K., & Najjar, S. M. (2026). Protecting CEACAM1 Expression Prevents Diet‐Induced Metabolic Dysfunction and Hepatic Fibrosis in Male Mice. Obesity. https://doi.org/10.1002/oby.70302
Vancouver
Abdolahipour R, Khuder SS, Philbrick WM, Portuphy AO, Belew GD, Fallouh HG, et al. Protecting CEACAM1 Expression Prevents Diet‐Induced Metabolic Dysfunction and Hepatic Fibrosis in Male Mice. Obesity. 2026. doi:10.1002/oby.70302
BibTeX
@article{Abdolahipour2026,
author = {Abdolahipour, Raziyeh and Khuder, Saja S and Philbrick, William M and Portuphy, Agnes O and Belew, Getachew D and Fallouh, Hatem G and Muturi, Harrison T and Kim, Boyeon and Kim, Jason K and Najjar, Sonia M},
title = {Protecting CEACAM1 Expression Prevents Diet‐Induced Metabolic Dysfunction and Hepatic Fibrosis in Male Mice},
journal = {Obesity},
year = {2026},
doi = {10.1002/oby.70302}
}
EUVIMED